ANDREW HULL - 23 Dec 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull
Issuer symbol
INM
Transactions as of
23 Dec 2023
Transactions value $
$0
Form type
4
Filing time
26 Dec 2023, 13:04:18 UTC
Previous filing
19 Dec 2022
Next filing
05 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +7,100 +478% $0.000000 8,584 23 Dec 2023 Common shares 7,100 $0.3700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner.